European Society of Cardiology (ESC)

This page includes news from the European Society of Cardiology (ESC). The ESC represents more than 95,000 men and women in the field of cardiology from Europe, the Mediterranean basin. It is the European umbrella cardiology organization, which includes the European Association of Percutaneous Cardiovascular Interventions (EAPCI), which hosts the large EuroPCR meeting; the European Heart Rhythm Society (EHRA); European Association of Cardiovascular Imaging (EACVI); European Association of Preventive Cardiology (EAPC); and the Association for Acute Cardiovascular Care (ACVC).

TAVR or TAVI? Cardiologists want a single acronym for the popular heart procedure
Clinicians are asking the world's medical societies to come together and agree on one acronym for TAVR/TAVI to avoid unnecessary confusion going forward.
Early outcomes with Myval TAVR valve comparable to popular devices from Medtronic, Edwards
Meril Life Sciences has been manufacturing its Myval heart valves for years. The devices are approved and available in both India and Europe, but they have not been approved by the FDA.
Surgery outperforms PCI in NSTEMI patients with multivessel CAD
CABG was associated with a 41% lower risk of long-term mortality than PCI in a new study of more than 57,000 patients. The full analysis was published in European Heart Journal.
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD
CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.
Predicting sudden cardiac death after a heart attack may be impossible—for now
Researchers tried to crack the code, but they fell short time and time again. AI may offer potential as one way to finally find an answer, they added.

A winning strategy for blood transfusions among anemic heart attack patients

Researchers detailed a method that improves patient safety and leads to significant cost savings.

Confirmed: Key heart medications safe to use for COVID-19 patients

The BRACE CORONA trial focused on the safety of taking angiotensin-converting enzyme inhibitors and angiotensin receptor blockers when hospitalized with COVID-19.

Why early rhythm control therapy is so important for atrial fibrillation patients

The research team's findings were presented at ESC Congress 2020 and published in the New England Journal of Medicine.

Shear wave imaging ‘extremely promising’ for assessment of myocardial stiffness in heart transplant recipients

The noninvasive technique shows potential where cardiac magnetic resonance imaging falls short.

Empagliflozin reduces risk of cardiovascular death, hospitalization among heart failure patients

The EMPEROR-Reduced trial included data from more than 3,700 adult patients with HF and a left ventricular ejection fraction of 40% or less.

How to predict a CVD patient’s risk of total, colorectal and lung cancer

The analysis was presented at ESC Congress 2020 and published in JACC: CardioOncology.

Burnout in cardiology: Most pediatric heart nurses feel exhausted, with 30% eyeing a career change

Nurses are unhappy with their working conditions, which leads to stress and exhaustion.

More cardiology conferences canceled over COVID-19 concerns

Healthcare conferences all over the world have been delayed or canceled due to the COVID-19 pandemic, and two more significant cancellations have been announced that impact cardiology professionals.

European Society of Cardiology (ESC)

TAVR or TAVI? Cardiologists want a single acronym for the popular heart procedure

Early outcomes with Myval TAVR valve comparable to popular devices from Medtronic, Edwards

Surgery outperforms PCI in NSTEMI patients with multivessel CAD

Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

Predicting sudden cardiac death after a heart attack may be impossible—for now